European Urology
Издатель: Elsevier · ISSN 0302-2838 · 79 статей
- Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Effect of [68Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings on Multiparametric MRI (PRIMARY2): A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Trial. Lancet Oncol 2026;27:839–848
- Reply to J.H. Kim and Y.S. Shin's Letter to the Editor re: Re: Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer–specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials Eur Urol 2026;90:225–238
- Reply to T. Takahashi's Letter to the Editor re: Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2026;90:225–238.
- Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol 2026;89:437–45
- Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer
- Re: Prostate Cancer
- Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial
- Re: Xenotransplantation of a Porcine Kidney for End-stage Kidney Disease
- Re: Reliability of Urological Telesurgery Compared with Local Surgery: Multicentre randomised controlled trial
- Re: Standardizing Time-to-Event Reporting in Single-arm BCG-unresponsive Registration Trials: A Case for Kaplan-Meier
- Re: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer
- Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma
- Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study
- Congress Calendar
- Single-port Robotic Retroperitoneal Nephroureterectomy with Lower Anterior Access: Surgical Technique, Perioperative and Early Oncological Outcomes from a Multi-institutional Series
- Re: Can Aydogdu, Laura Bukavina, Liang Cheng, et al. Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.05.030
- Diagnostic Performance of Nectin-4–targeted [68Ga]Ga-DOTA-N188 PET/CT versus [18F]-FDG PET/CT for Staging of Locally Advanced and Metastatic Urothelial Carcinoma: A Prospective, Single-center, Phase 2 Feasibility Trial
- Key Determinants and Clinical Impact of Male Factor Infertility: From Etiology to Treatment
- Which Patients with Advanced Clear Cell Renal Cell Carcinoma Benefit Most from First-line Checkpoint Inhibitor Combination Regimens: A Meta-analysis of Individual Patient Data and Aggregate Data from Randomised Trials